VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 11 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4 | +33.3% | 11,907 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 11,907 | -0.9% | 0.00% | – |
| Q3 2022 | $3,000 | -62.5% | 12,021 | -0.2% | 0.00% | – |
| Q2 2022 | $8,000 | -72.4% | 12,040 | -22.0% | 0.00% | – |
| Q1 2022 | $29,000 | +383.3% | 15,427 | +1335.1% | 0.00% | – |
| Q4 2021 | $6,000 | – | 1,075 | +6223.5% | 0.00% | – |
| Q2 2021 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 15 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,569 | $13,000 | 0.00% |
| CITIGROUP INC | 6,000 | $4,000 | 0.00% |
| North Star Investment Management Corp. | 1,750 | $1,000 | 0.00% |
| MORGAN STANLEY | 50 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 35,798 | $23,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,040 | $8,000 | 0.00% |
| Renaissance Technologies | 78,888 | $50,000 | 0.00% |
| VANGUARD GROUP INC | 23,464 | $15,000 | 0.00% |